Myungmoon stocks set fresh records

Published: 2009-09-02 06:57:00

Updated: 2009-09-02 06:57:00

Shares of Myungmoon Pharm jumped from 3,820 won to 6,650 won between August 25 and 28, after the company reported its agreement with Pharmswell Bio which has a capacity to produce Tamiflu.

The company said the agreement is aimed at securing the raw materials of Tamiflu, when the Korean governm...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK